New York Adopts Uniform Medication Rules

 

The new regulations are modeled on uniform medication rules developed by the Association of Racing Commissioners International.

 

"These new rules are in the best interest of the health and welfare of the racehorses, the safety of all participants and further promote the integrity of thoroughbred horse racing," said New York Racing Association Chief Executive Officer and President Christopher K. Kay. "The adoption of these regulations by the Gaming Commission is another step forward in the ongoing efforts of thoroughbred racing regulators in many states and other participants to adopt uniform and effective equine medication rules across the country."

 

Last month, Kay expressed the New York Racing Association's enthusiastic support of the new regulations.

 

Kay noted that when the NYRA Reorganization Board was formed in 2012, it established two Board Committees, Equine Safety and Racing, to review and monitor safety, integrity and related medication issues. These Board Committees worked with New York Racing Association management to establish an industry-leading program of surveillance and testing to ensure compliance with the Gaming Commission's medications regulations.

Based on input from these committees and experts, the New York Racing Association Board of Directors authorized management to publicly support the proposed regulations, which reflect the organization's continued commitment to equine safety and the integrity of thoroughbred racing.

 

Source: NYRA Communications